WebSite > HUARONG(GUANGDONG) PHARMACEUTICAL CO.,LTD

HUARONG(GUANGDONG) PHARMACEUTICAL CO.,LTD

  • Company Name HUARONG(GUANGDONG) PHARMACEUTICAL CO.,LTD
  • Tel 0086-+86-0086-13751168070
  • Email sales@huarongpharma.com
  • WebSite www.huarongpharma.com/
  • CB Index 58
  •       Founded in 2016, Huarong (Guangdong) Pharmaceutical Co., Ltd. is a new chemical manufacturer integrating scientific research, production and supply. The main customers are located in Southeast Asia, the Middle East,India, Africa, Australia, Europe, the United States and other countries. Huarong (Guangdong) Pharmaceutical Co., Ltd has its own chemical product production park, more than 150 employees, more than 50000 square meters of workshop, research and development, storage area, laboratory and workshop. In strict accordance with GMP standards, Huarong (Guangdong) Pharmaceutical Co., Ltd strives to provide customers with better products and services and create more added value. we have investment 27.8 millionUSD,Annual Capacity is 4000/tons per year,Annual Revenue USD is 139 million/Year.
HUARONG(GUANGDONG) PHARMACEUTICAL CO.,LTD Product List
  •  
  • Product Name Sermorelin
  • MF C149H246N44O42S
  • CAS 86168-78-7
  •  
  • Product Name Selank
  • MF C33H57N11O9
  • CAS 129954-34-3
  •  
  •  
  • Product Name Thymalin
  • MF C33H54N12O15
  • CAS 63958-90-7
  •  
  •  
  • Product Name Dermorphin
  • MF C40H50N8O10
  • CAS 77614-16-5
  •  
  •  
  • Product Name Semax
  • MF C37H51N9O10S
  • CAS 80714-61-0
  •  
  • Product Name GAA
  • MF C3H7N3O2
  • CAS 352-97-6
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name L-Alanine
  • MF C3H7NO2
  • CAS 56-41-7
  •  
  •  
  •  
  •  
  • Product Name L-Tyrosine
  • MF C9H11NO3
  • CAS 60-18-4
  •  
  •  
  • Product Name DL-Alanine
  • MF C3H7NO2
  • CAS 302-72-7
  •  
  •  
  •  
  •  
  • Product Name β-Alanine
  • MF C3H7NO2
  • CAS 107-95-9
  •  
  • Product Name Taurine
  • MF C2H7NO3S
  • CAS 107-35-7
  •  
  •  
  • Product Name L-Lysine
  • MF C6H14N2O2
  • CAS 56-87-1
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •